Skip to content

Accounts Payable at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$10.46B+9.6%
Merck & Co. logo
Merck & Co.MRK
$3.86B+2.1%
UroGen Pharma logo
UroGen PharmaURGN
$35.35M+16.6%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$20.74M+17.6%
CG Oncology logo
CG OncologyCGON
$8.24M+22.4%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$5.73M+353%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s accounts payable?
Aura Biosciences, Inc. (AURA) reported accounts payable of $2.57M in Q1 2026.
How has Aura Biosciences, Inc.'s accounts payable changed year-over-year?
Aura Biosciences, Inc.'s accounts payable increased by 28.3% year-over-year, from $2.01M to $2.57M.
What is the long-term trend for Aura Biosciences, Inc.'s accounts payable?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s accounts payable has grown at a 4.0% compound annual growth rate (CAGR), from $5.75M to $6.73M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.